SPOTLIGHT -
Slideshow
Author(s):
Treatment failure risk is high, new biomarker of conversion from major depressive disorder, depression stifles creativity, and other recent findings are summarized here.
Diagnosis in Bipolar Disorder: Dealing With Comorbidity
Blue Light, Depression, and Bipolar Disorder
April in Review: Updates on the Psychiatric Treatment Pipeline
Four Myths About Lamotrigine
Online Survey Reveals Clinicians’ Top Concerns in BDI, Schizophrenia Treatment
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia